Based on disulfidptosis, revealing the prognostic and immunological characteristics of renal cell carcinoma with tumor thrombus of vena cava and identifying potential therapeutic target AJAP1-Reference-Cited by-同舟云学术

Based on disulfidptosis, revealing the prognostic and immunological characteristics of renal cell carcinoma with tumor thrombus of vena cava and identifying potential therapeutic target AJAP1

Published:2023-05-29 Issue:12 Volume:149 Page:9787-9804
ISSN:0171-5216
Container-title:Journal of Cancer Research and Clinical Oncology
language:en
Short-container-title:J Cancer Res Clin Oncol

Author:

Yang Lin,Liu Jiahao,Li Sheng,Liu Xiaoqiang,Zheng Fuchun,Xu Songhui,Fu Bin,Xiong Jing

Funder

Jiangxi Provincial Health Technology Projec

Jiangxi Provincial "Double Thousand Plan" Fund Project

Key Project of Natural Science Foundation of Jiangxi Province

Youth Project of Natural Science Foundation of Jiangxi Province

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s00432-023-04877-x.pdf

Reference37 articles.

1. Abaza R, Eun DD, Gallucci M, Gill IS, Menon M, Mottrie A et al (2016) Robotic surgery for renal cell carcinoma with vena caval tumor thrombus. Eur Urol Focus 2(6):601–607. https://doi.org/10.1016/j.euf.2017.01.001

2. Abel EJ, Spiess PE, Margulis V, Master VA, Mann M, Zargar-Shoshtari K et al (2017) Cytoreductive nephrectomy for renal cell carcinoma with venous tumor thrombus. J Urol 198(2):281–288. https://doi.org/10.1016/j.juro.2017.03.011

3. Al Otaibi M, Abou Youssif T, Alkhaldi A, Sircar K, Kassouf W, Aprikian A et al (2009) renal cell carcinoma with inferior vena caval extention: impact of tumour extent on surgical outcome. BJU Int 104(10):1467–1470. https://doi.org/10.1111/j.1464-410X.2009.08575.x

4. Bader JE, Voss K, Rathmell JC (2020) Targeting metabolism to improve the tumor microenvironment for cancer immunotherapy. Mol Cell 78(6):1019–1033. https://doi.org/10.1016/j.molcel.2020.05.034

5. Bedke J, Albiges L, Capitanio U, Giles RH, Hora M, Lam TB et al (2022) 2021 updated European Association of urology Guidelines on the use of adjuvant pembrolizumab for renal cell carcinoma. Eur Urol 81(2):134–137. https://doi.org/10.1016/j.eururo.2021.11.022

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comprehensive identification of a disulfidptosis-associated long non-coding RNA signature to predict the prognosis and treatment options in ovarian cancer;Frontiers in Endocrinology;2024-09-13

2. Identifying and evaluating a disulfidptosis-related gene signature to predict prognosis in colorectal adenocarcinoma patients;Frontiers in Immunology;2024-06-19

3. Identification of Key Disulfidptosis-Related Genes and Their Association with Gene Expression Subtypes in Crohn’s Disease;Journal of Inflammation Research;2024-06

4. Disulfidptosis‑related lncRNA prognosis model to predict survival therapeutic response prediction in lung adenocarcinoma;Oncology Letters;2024-05-29

5. Constructing a disulfidptosis-related prognostic signature of hepatocellular carcinoma based on single-cell sequencing and weighted co-expression network analysis;Apoptosis;2024-05-17